Pharmaceutical Technology Europe, Oct 1, 2009 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Oct 1, 2009
Manufacturing
Microreactor technology: Is the industry ready for it yet?
By Fedra Pavlou
Microreactor technology (MRT) has recently been introduced to the pharmaceutical manufacturing circuit as a promising technology for the continuous processing of commercial quantities of pharmaceuticals.
Removing endotoxin from biopharmaceutical solutions
By Valencio Salema , Lalit Saxena , Priyabrata Pattnaik
Endotoxin removal from a finished product is a major challenge for biopharmaceutical manufacturers; particularly as all endotoxin removal methods have operational limitations and may result in loss of protein.
Formulation
Defining the ideal properties of a moisture protective, instant release film coating
By Thorsten Cech , Maureen Mistry
Applying a moisture protective barrier to tablet cores can help prevent degradation caused by ambient moisture.
Developing robust formoterol-containing suspension pMDIs with enhanced shelf lives
By Alex Slowey , Louise Righton , Paul Bainbridge
Formoterol presents formulators and manufacturers in the asthma and chronic obstructive pulmonary disease marketplace many challenges.
Special Report
Is all sunny in Spanish pharma?
By Stephanie Sutton
Despite the economic downturn, Spain's pharmaceutical industry continues to grow — particularly when it comes to biotechnology.
Ask the Expert
How to manage the threat of the global supply chain and save money
By Julian Mosquera
Julian Mosquera, Director of LCP Consulting, advises how pharma companies can make their supply chains leaner.
Spotlight On...
The rise of in silico R&D
By Faiz Kermani
Even though the pharmaceutical industry has come to recognize the importance and associated benefits of using computers, evolving computer-based simulation technology has still to make a suitable impression.
Interview
A new tool to battle counterfeits
By Jeff Robertson
Jeff Robertson talks about a unique form of micro-tag technology that can be applied to solid dose pharmaceuticals.
News
News
A roundup of news including: Outsourcing undervalued; The real cost of REACH
Editor's Comment
MRT coming soon to a plant near you
By Fedra Pavlou
Well, the summer's well and truly behind us and Madrid beckons for this year's CPhI Worldwide.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here